Literature DB >> 33810401

Effect of Inactivation Methods on SARS-CoV-2 Virion Protein and Structure.

Emma K Loveday1, Kyle S Hain2, Irina Kochetkova2, Jodi F Hedges2, Amanda Robison2, Deann T Snyder2, Susan K Brumfield3, Mark J Young3, Mark A Jutila2, Connie B Chang1, Matthew P Taylor2.   

Abstract

The risk posed by Severe Acute Respiratory Syndrome Coronavirus -2 (SARS-CoV-2) dictates that live-virus research is conducted in a biosafety level 3 (BSL3) facility. Working with SARS-CoV-2 at lower biosafety levels can expedite research yet requires the virus to be fully inactivated. In this study, we validated and compared two protocols for inactivating SARS-CoV-2: heat treatment and ultraviolet irradiation. The two methods were optimized to render the virus completely incapable of infection while limiting the destructive effects of inactivation. We observed that 15 min of incubation at 65 °C completely inactivates high titer viral stocks. Complete inactivation was also achieved with minimal amounts of UV power (70,000 µJ/cm2), which is 100-fold less power than comparable studies. Once validated, the two methods were then compared for viral RNA quantification, virion purification, and antibody detection assays. We observed that UV irradiation resulted in a 2-log reduction of detectable genomes compared to heat inactivation. Protein yield following virion enrichment was equivalent for all inactivation conditions, but the quality of resulting viral proteins and virions were differentially impacted depending on inactivation method and time. Here, we outline the strengths and weaknesses of each method so that investigators might choose the one which best meets their research goals.

Entities:  

Keywords:  ELISA; SARS-CoV-2; UV inactivation; electron microscopy; heat inactivation; western blot

Year:  2021        PMID: 33810401     DOI: 10.3390/v13040562

Source DB:  PubMed          Journal:  Viruses        ISSN: 1999-4915            Impact factor:   5.048


  13 in total

Review 1.  Loop-Mediated Isothermal Amplification Detection of SARS-CoV-2 and Myriad Other Applications.

Authors:  Keith J M Moore; Jeremy Cahill; Guy Aidelberg; Rachel Aronoff; Ali Bektaş; Daniela Bezdan; Daniel J Butler; Sridar V Chittur; Martin Codyre; Fernan Federici; Nathan A Tanner; Scott W Tighe; Randy True; Sarah B Ware; Anne L Wyllie; Evan E Afshin; Andres Bendesky; Connie B Chang; Richard Dela Rosa; Eran Elhaik; David Erickson; Andrew S Goldsborough; George Grills; Kathrin Hadasch; Andrew Hayden; Seong-Young Her; Julie A Karl; Chang Hee Kim; Alison J Kriegel; Thomas Kunstman; Zeph Landau; Kevin Land; Bradley W Langhorst; Ariel B Lindner; Benjamin E Mayer; Lee A McLaughlin; Matthew T McLaughlin; Jenny Molloy; Christopher Mozsary; Jerry L Nadler; Melinee D'Silva; David Ng; David H O'Connor; Jerry E Ongerth; Olayinka Osuolale; Ana Pinharanda; Dennis Plenker; Ravi Ranjan; Michael Rosbash; Assaf Rotem; Jacob Segarra; Stephan Schürer; Scott Sherrill-Mix; Helena Solo-Gabriele; Shaina To; Merly C Vogt; Albert D Yu; Christopher E Mason
Journal:  J Biomol Tech       Date:  2021-09

2.  Efficient and Sustainable Platform for Preparation of a High-Quality Immunoglobulin G as an Urgent Treatment Option During Emerging Virus Outbreaks.

Authors:  Tihana Kurtović; Sanda Ravlić; Adela Štimac; Sanja Mateljak Lukačević; Ana Hećimović; Saša Kazazić; Beata Halassy
Journal:  Front Immunol       Date:  2022-05-17       Impact factor: 8.786

3.  Preclinical coronavirus studies and pathology: Challenges of the high-containment laboratory.

Authors:  Victoria K Baxter; Stephanie A Montgomery
Journal:  Vet Pathol       Date:  2022-04-11       Impact factor: 3.157

4.  SARS-CoV-2 spike protein binding selectively accelerates substrate-specific catalytic activity of ACE2.

Authors:  Anna A Kiseleva; Elizabeth M Troisi; Scott E Hensley; Rahul M Kohli; Jonathan A Epstein
Journal:  J Biochem       Date:  2021-10-11       Impact factor: 3.241

5.  Pannexin-1 channel opening is critical for COVID-19 pathogenesis.

Authors:  Ross Luu; Silvana Valdebenito; Eliana Scemes; Antonio Cibelli; David C Spray; Maximiliano Rovegno; Juan Tichauer; Andrea Cottignies-Calamarte; Arielle Rosenberg; Calude Capron; Sandrine Belouzard; Jean Dubuisson; Djillali Annane; Geoffroy Lorin de la Grandmaison; Elisabeth Cramer-Bordé; Morgane Bomsel; Eliseo Eugenin
Journal:  iScience       Date:  2021-11-19

Review 6.  SARS-CoV-2 Diagnostics Based on Nucleic Acids Amplification: From Fundamental Concepts to Applications and Beyond.

Authors:  João M Vindeirinho; Eva Pinho; Nuno F Azevedo; Carina Almeida
Journal:  Front Cell Infect Microbiol       Date:  2022-03-23       Impact factor: 5.293

7.  Functional profiling of Covid 19 vaccine candidate by flow virometry.

Authors:  Ashley Prout; Richard R Rustandi; Christopher Tubbs; Michael A Winters; Philip McKenna; Josef Vlasak
Journal:  Vaccine       Date:  2022-08-09       Impact factor: 4.169

8.  SARS-CoV-2 productively infects primary human immune system cells in vitro and in COVID-19 patients.

Authors:  Marjorie C Pontelli; Ítalo A Castro; Ronaldo B Martins; Leonardo La Serra; Flávio P Veras; Daniele C Nascimento; Camila M Silva; Ricardo S Cardoso; Roberta Rosales; Rogério Gomes; Thais M Lima; Juliano P Souza; Brenda C Vitti; Diego B Caetité; Mikhael H F de Lima; Spencer D Stumpf; Cassandra E Thompson; Louis-Marie Bloyet; Juliana E Toller-Kawahisa; Marcela C Giannini; Letícia P Bonjorno; Maria I F Lopes; Sabrina S Batah; Li Siyuan; Rodrigo Luppino-Assad; Sergio C L Almeida; Fabiola R Oliveira; Maíra N Benatti; Lorena L F Pontes; Rodrigo C Santana; Fernando C Vilar; Maria Auxiliadora-Martins; Pei-Yong Shi; Thiago M Cunha; Rodrigo T Calado; José C Alves-Filho; Dario S Zamboni; Alexandre T Fabro; Paulo Louzada-Junior; Rene D R Oliveira; Sean P J Whelan; Fernando Q Cunha; Eurico Arruda
Journal:  J Mol Cell Biol       Date:  2022-08-17       Impact factor: 8.185

Review 9.  Disinfection and decontamination in the context of SARS-CoV-2-specific data.

Authors:  Nevio Cimolai
Journal:  J Med Virol       Date:  2022-07-18       Impact factor: 20.693

10.  An ADAM17-Neutralizing Antibody Reduces Inflammation and Mortality While Increasing Viral Burden in a COVID-19 Mouse Model.

Authors:  Jodi F Hedges; Deann T Snyder; Amanda Robison; Heather M Grifka-Walk; Karlin Blackwell; Kelly Shepardson; Douglas Kominsky; Agnieszka Rynda-Apple; Bruce Walcheck; Mark A Jutila
Journal:  Front Immunol       Date:  2022-06-10       Impact factor: 8.786

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.